Fresenius Medical Care AG & Co. KGaA (FMS) Competitors $24.97 -0.29 (-1.15%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$24.96 -0.01 (-0.04%) As of 09/12/2025 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FMS vs. ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, NTRA, and HIMSShould you be buying Fresenius Medical Care AG & Co. KGaA stock or one of its competitors? The main competitors of Fresenius Medical Care AG & Co. KGaA include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. Fresenius Medical Care AG & Co. KGaA vs. Its Competitors Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera Hims & Hers Health Aclarion (NASDAQ:ACONW) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends. Which has stronger valuation and earnings, ACONW or FMS? Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Aclarion. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$62.95KN/AN/AN/AN/AFresenius Medical Care AG & Co. KGaA$20.63BN/A$582.08M$1.2220.47 Do analysts rate ACONW or FMS? Fresenius Medical Care AG & Co. KGaA has a consensus target price of $27.80, indicating a potential upside of 11.33%. Given Fresenius Medical Care AG & Co. KGaA's stronger consensus rating and higher probable upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Aclarion.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Fresenius Medical Care AG & Co. KGaA 2 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.83 Does the media refer more to ACONW or FMS? In the previous week, Fresenius Medical Care AG & Co. KGaA had 1 more articles in the media than Aclarion. MarketBeat recorded 2 mentions for Fresenius Medical Care AG & Co. KGaA and 1 mentions for Aclarion. Aclarion's average media sentiment score of 1.91 beat Fresenius Medical Care AG & Co. KGaA's score of 0.84 indicating that Aclarion is being referred to more favorably in the media. Company Overall Sentiment Aclarion Very Positive Fresenius Medical Care AG & Co. KGaA Positive Is ACONW or FMS more profitable? Fresenius Medical Care AG & Co. KGaA has a net margin of 3.39% compared to Aclarion's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 6.75% beat Aclarion's return on equity.Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A Fresenius Medical Care AG & Co. KGaA 3.39%6.75%3.13% Do institutionals & insiders believe in ACONW or FMS? 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryFresenius Medical Care AG & Co. KGaA beats Aclarion on 9 of the 10 factors compared between the two stocks. Get Fresenius Medical Care AG & Co. KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FMS vs. The Competition Export to ExcelMetricFresenius Medical Care AG & Co. KGaAMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket CapN/A$6.95B$5.87B$21.68BDividend Yield2.26%1.21%5.68%3.48%P/E Ratio20.4725.5274.5229.69Price / SalesN/A192.64537.1770.24Price / Cash5.1922.1337.5625.00Price / Book0.865.0012.164.58Net Income$582.08M$176.38M$3.28B$1.00B7 Day Performance0.92%1.00%0.87%0.65%1 Month Performance0.43%0.74%4.96%3.07%1 Year Performance18.40%10.34%60.74%14.34% Fresenius Medical Care AG & Co. KGaA Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FMSFresenius Medical Care AG & Co. KGaA3.8249 of 5 stars$24.97-1.1%$27.80+11.3%+23.7%$0.00$20.63B20.471,384News CoverageACONWAclarionN/A$0.04+12.4%N/A+6.0%$0.00$62.95K0.007Positive NewsGap UpAONCAmerican Oncology NetworkN/A$10.71-3.9%N/A+205.6%$0.00$1.34B0.001,520Short Interest ↑High Trading VolumeDHACWDigital Health AcquisitionN/A$0.02-36.1%N/AN/A$0.00N/A0.00N/AGap DownHigh Trading VolumeLFMDPLifeMDN/A$22.95-3.4%N/A+7.4%$0.00$245.56M0.00230Positive NewsShort Interest ↓Gap DownOTRKPOntrakN/A$0.02-5.7%N/A-84.0%$0.00$10.84M0.00250Gap DownHigh Trading VolumePIIIWP3 Health PartnersN/A$0.01flatN/A-73.5%$0.00$1.46B0.00500Positive NewsTALKWTalkspaceN/A$0.09-8.1%N/A+53.6%$0.00$202.61M0.00500Positive NewsGap DownTOIIWOncology InstituteN/A$0.14-0.2%N/A+544.2%$0.00$424.38M0.00660Positive NewsNTRANatera3.6584 of 5 stars$168.25+0.2%$193.19+14.8%+34.7%$23.09B$1.70B-88.094,434Positive NewsHIMSHims & Hers Health2.5045 of 5 stars$42.36-4.0%$38.92-8.1%+250.7%$9.57B$2.01B52.951,637Trending NewsAnalyst Forecast Related Companies and Tools Related Companies ACONW Competitors AONC Competitors DHACW Competitors LFMDP Competitors OTRKP Competitors PIIIW Competitors TALKW Competitors TOIIW Competitors NTRA Competitors HIMS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:FMS) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius Medical Care AG & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresenius Medical Care AG & Co. KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FMS Stock Alerts